APRIL 18 - 22, 2018 Gaylord National Resort & Convention Center National Harbor, Maryland - Combined Otolaryngology Spring ...
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
Gaylord National Resort & Convention Center National Harbor, Maryland APRIL 18 – 22, 2018
Harvest results,
not patient tissue.1
The Biodesign® Otologic Repair Graft, indicated for use in
tympanoplasty and myringoplasty, is easy to manipulate, allows
for improved surgical precision during graft placement, and
reduces the need to harvest autologous tissue, which decreases
intraoperative time an average of 10 minutes. 2
Join us at
our booth
#
430
1. D’Eredità R. Porcine small intestinal submucosa (SIS) myringoplasty
in children: a randomized controlled study. Int J Pediatr
Otorhinolaryngol. 2015;79(7):1085-1089.
2. De Zinis LO, Berlucchi M, Nassif N. Double-handed endoscopic
myringoplasty with a holding system in children: preliminary
observations. Int J Pediatr Otorhinolaryngol. 2017;96:127-130.
cookmedical.com
© COOK 03/2018 OHNS-D41670-EN
DOWNLOAD NOW!
The COSM 2018
Annual Meeting App!
FEATURES INCLUDE:
• Oral presentation & Poster abstracts 9:15 AM
• Meeting program and course schedules
Dashboard
• Customizable calendar and itinerary builder
• Social media interaction
My Schedule What’s On Program Speakers
Now
• Exhibitor listing with booth map
• Meeting alerts Posters Exhibitors Maps COSM /
Society Info
Event Pulse Social Attendees Local Places
Networking
Downloads CME
About this show About this app
COSM 2017
About this show About this app
Scan the QR code above, or point the browser on your mobile Downloads CME
device to app.core-apps.com/tristar_cosm
Networking
Event Pulse Social Attendees Local Places
The COSM 2018 Annual Meeting App is compatible with iPhone, Android, iPad and most tablets.
Society Info
Posters Exhibitors Maps COSM /
COSM 2018 PROGRAM GUIDE
Table of COSM Secretaries
Liaison Committee
Contents Gregory Grillone,
MD, FACS
Chair
COSM Secretaries
Liaison Committee
Theda Kontis, MD
Schedule-at-a-Glance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4 American Academy of Facical Plastic and
Reconstructive Surgery (AAFPRS)
General Information . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6
Seth Dailey, MD
American Broncho-Esophagological
DAILY SCHEDULE Association (ABEA)
Brian Burkey, MD, MEd, FACS
Societies are listed in alphabetical order:
American Head and Neck Society (AHNS)
American Academy of Facial Plastic
and Reconstructive Surgery (AAFPRS) . . . . . . . . . . . . . . . . . . . 12–13, 15–16 Lucian Sulica, MD
American Laryngological Association (ALA)
American Broncho-Esophagological Association (ABEA) . . . . . . . . 9, 20, 27
Brad Kesser, MD
American Head and Neck Society (AHNS) . . . . . . . . . . . . . . . . 10–12, 17–18 American Neurotology Society (ANS)
American Laryngological Association (ALA) . . . . . . . . . . . . . . . . . . 14, 19, 26 Sujana Chandrasekhar, MD, FACS
American Otological Society (AOS)
American Neurotology Society (ANS) . . . . . . . . . . . . . . . . . . . . . . . . . . 34–36
Pete Batra, MD, FACS
American Rhinologic Society (ARS)
American Otological Society (AOS) . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27–29
American Rhinologic Society (ARS) . . . . . . . . . . . . . . . . . . . . . . . . . . . 21–24 Anna Messner, MD, FACS
American Society of Pediatric Otolaryngology
(ASPO)
American Society of Pediatric Otolaryngology (ASPO) . . . 28, 30–32, 36–37
Myles Pensak, MD, FACS
The Triological Society (TRIO) . . . . . . . . . . . . . . . . . . . . . . . . . . 25–26, 32–34 American Laryngological, Rhinological and
Otological Society aka The Triological Society
1st Combined Posters (AAFPRS, ABEA, AHNS, ALA, ARS) . . . . . . . . . 38–53 (TRIO)
2nd Combined Posters (ANS, AOS, ASPO, TRIO) . . . . . . . . . . . . . . . . 54–65
Connect with Us!
Business and Social Events . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 66
COSM
Exhibitor Listings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 67–71 c/o American College of Surgeons
Gaylord National Resort & Convention Center Floorplan . . . . . . . . . . . . . . 72 633 N. Saint Clair Street
Chicago, IL 60611
312-202-5322
cosmsupport@facs.org
www.cosm.md
DOWNLOAD THE MEETING APP! www.twitter.com/__COSM
#2018COSM
Download the COSM ©2018.
Meeting App for the most TriStar Publishing, Inc.
7285 W.132nd Street, Suite 300
up-to-date program and Overland Park, KS 66213
event information! 913-491-4200 | www.tristarpub.com
COSM 2017
2 2018 Combined Otolaryngology Spring Meetings
Visit the Merck Booth and Learn More About KEYTRUDA • Approved indications • Resources for health care professionals • The Merck Access Program • KEY+YOU Patient Support Program Copyright © 2017 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. All rights reserved. ONCO-1215358-0001 04/17 keytruda.com
COSM 2018 PROGRAM GUIDE
Schedule-at-a-Glance
WEDNESDAY THURSDAY FRIDAY SATURDAY SUNDAY
APRIL 18 APRIL 19 APRIL 20 APRIL 21 APRIL 22
ABEA AAFPRS ARS C AOS ANS
MORNING
AHNS C AHNS C TRIO C ASPO C ASPO C
ALA TRIO
AAFPRS ABEA ALA/ABEA ANS
AFTERNOON
AHNS C AHNS C AOS ASPO C
ALA ARS ARS TRIO
ASPO
ALA R 1st Poster R 2nd Poster R AOS B
AAFPRS, ABEA, ANS, AOS, ASPO B
EVENING
AHNS, ALA, ARS ASPO, TRIO
AHNS R ANS R
ALA R ASPO R
ARS R
B = Banquet C = Concurrent R = Reception
COSM SOCIETIES
AAFPRS AOS
American Academy of Facial Plastic and American Otological Society
Reconstructive Surgery www.americanotologicalsociety.org
www.aafprs.org
ARS
ABEA American Rhinologic Society
American Broncho-Esophagological Association www.american-rhinologic.org
www.abea.net
ASPO
AHNS American Society of Pediatric Otolaryngology
American Head and Neck Society www.aspo.us
www.ahns.info
TRIO
ALA American Laryngological, Rhinological and
American Laryngological Association Otological Society aka The Triological Society
www.alahns.org www.triological.org
ANS
American Neurotology Society
www.americanneurotologysociety.com
4 2018 Combined Otolaryngology Spring Meetings
Less heat
means
less pain
Low temperature COBLATION Plasma
Technology is designed to minimize
thermal damage during tonsillectomy, COBLATION™
resulting in less pain one day after surgery.1 Plasma Technology
for Adenotonsillectomy
Visit booth #323 to learn more.
1. Data on file at Smith & Nephew, report P/N 91999.
Smith & Nephew, Inc. www.smith-nephew.com ™ Trademark of Smith & Nephew.
150 Minuteman Road T +1 978 749 1000 ©2018 Smith & Nephew. All rights reserved.
Andover, MA 01810 USA US Customer Service: +1 800 343 5717 Printed in USA. 14050-2 V1 03/18
COSM 2018 PROGRAM GUIDE
General Information
POSTERS
All room locations are located within the Gaylord National Resort You may view all Posters via www.cosm.md,
& Convention Center, unless otherwise noted. the Mobile App, and onsite in Prince George’s
Exhibit Hall A.
Thursday, April 19 . . . . . . . 9:00 am – 4:00 pm
ADMISSION REQUIREMENTS HEADQUARTERS HOTEL
Friday, April 20 . . . . . . . . . . 9:00 am – 4:00 pm
A common registration badge is used by Gaylord National Resort
Saturday, April 21 . . . . . . . . 9:00 am – 4:00 pm
participating societies. The acronym of each & Convention Center
society an attendee is registered for will be 201 Waterfront Street Additionally, posters are available for viewing
printed on the badge. Ribbons on the badge National Harbor, MD 20745 during the Combined Poster Receptions
indicate those societies of which the attendee 301-965-4000 (Prince George’s Exhibit Hall A):
is a member. A badge must be worn to enter 1st Poster Reception
the exhibit hall, scientific sessions, and the HEADQUARTERS OFFICE (AAFPRS, ABEA, AHNS, ALA, and ARS)
spouse/guest hospitality lounge. Maryland C Registration Desk Office Thursday, April 19 . . . . . . . . . . . 5:30 – 7:00 pm
Wednesday, April 18 . . . . . . 6:30 am – 5:00 pm
BUSINESS CENTER Thursday, April 19 . . . . . . . . 7:00 am – 5:00 pm 2nd Poster Reception
The business center is staffed from 6:00 am to Friday, April 20 . . . . . . . . . . 7:00 am – 5:00 pm (ANS, AOS, ASPO and TRIO)
9:00 pm daily and offers 24 hour self-service Saturday, April 21 . . . . . . . . 7:00 am – 5:00 pm Friday, April 20 . . . . . . . . . . . . . 5:30 – 7:00 pm
printing, copying, and internet access. The Sunday, April 22 . . . . . . . . 7:00 am – 12:00 pm
business center is located on 2nd floor and PRESS OFFICE
can be reached at 301-567-0457. LOST AND FOUND Members of the press may pick up a press
Security is alerted if a guest is trying to locate badge and kit in the COSM Headquarters Office,
CHILD POLICY an item. There is a voicemail system in place Maryland C Registration Desk Office. All inter-
Younger than 16: Not permitted on Exhibit for inquiries. Please contact 301-965-4520, views must be conducted in the Press Office.
Hall floor or scientific sessions. leave a message and a security agent will
return your call. REGISTRATION
16 and older: Must have a badge to enter LOCATION & HOURS:
the Exhibit Hall or meeting rooms. This policy
MESSAGES Maryland Ballroom Foyer
includes infants in strollers and arms. Tuesday, April 17 . . . . . . . . . . 5:00 – 7:00 pm*
A message board is located by COSM
Registration in the Maryland Ballroom Foyer. Wednesday, April 18 . . . . . . 6:30 am – 5:00 pm
CONTINUING MEDICAL Thursday, April 19 . . . . . . . . 7:00 am – 5:00 pm
EDUCATION CREDIT Anyone wishing to post a message for an
attendee may do so. Friday, April 20 . . . . . . . . . . 7:00 am – 5:00 pm
Please refer to www.cosm.md for CME Saturday, April 21 . . . . . . . . 7:00 am – 3:00 pm
information; CME credits/certificates will be
NURSING ROOM Sunday, April 22 . . . . . . . . . . . 7:00 – 10:00 am
processed by participating Societies.
Please contact COSM Headquarters in *subject to change
EMERGENCY INFORMATION Maryland C Registration Desk Office to make
arrangements. SPEAKER READY ROOM
All emergencies or suspicious activities should be Chesapeake K
reported immediately to Safety Services. Safety
PARKING Tuesday, April 17 . . . . . . . . . . . 4:00 – 8:00 pm
Services can be contacted by any house phone Wednesday, April 18 . . . . . . 6:00 am – 6:00 pm
Self Parking:
or dialing 333 from your guest room phone. Thursday, April 19 . . . . . . . . 6:00 am – 6:00 pm
0-1 Hour . . . . . . . . . . . . . . . . . . . . . . . . . . $12
1-2 Hours . . . . . . . . . . . . . . . . . . . . . . . . . $18 Friday, April 20 . . . . . . . . . . 6:00 am – 6:00 pm
EXHIBIT HALL
2-3 Hours . . . . . . . . . . . . . . . . . . . . . . . . . $22 Saturday, April 21 . . . . . . . . 7:00 am – 6:00 pm
The Exhibits are located in the Prince George’s
3- 24 Hours . . . . . . . . . . . . . . . . . . . . . . . $30 Sunday, April 22 . . . . . . . . . . . 7:00 – 10:00 am
Exhibit Hall A. Coffee breaks and lunch daily
(Wednesday and Sunday excluded) will be Valet Parking: WIFI
served in the Exhibit Hall. 0-2 Hours . . . . . . . . . . . . . . . . . . . . . . . . . $24 Complimentary internet access is available
2-24 Hours . . . . . . . . . . . . . . . . . . . . . . . . $43 in main lobby and in the atrium. COSM has
Thursday, April 19 . . . . . . . . 9:00 am – 4:00 pm
Friday, April 20 . . . . . . . . . . 9:00 am – 4:00 pm purchased wifi in the meeting room level
Saturday, April 21 . . . . . . . . 9:00 am – 4:00 pm Wednesday-Sunday.
Network: COSM2018 | Password: cosm2018
COSM MISSION
The mission of the Combined Otolaryngology Spring Meetings (COSM) is to bring together the membership of the COSM societies,
Otolaryngology residents in training, medical students and allied health professionals for the purpose of disseminating and exchanging
the latest cutting edge clinical and basic scientific research. COSM is the premier educational and technology forum for providing the sub
specialties in Otolaryngology – Head and Neck Surgery with an opportunity to improve and expand their knowledge and skills thereby
enhancing the quality of patient care.
6 2018 Combined Otolaryngology Spring Meetings
The first and only combination ear drop for AOMT in single-use vials 1
For treatment of acute otitis media in children with tympanostomy tubes (6 months and older)
due to S. aureus, S. pneumoniae, H. influenzae, M. catarrhalis, and P. aeruginosa.
Single. Sterile. Simple.
The first and only combination ear drop in single-dose vials1
• Single-use vials contain 1 premeasured dose each—dose
BID/7 days
• Every dose is sterile, precise, and preservative free
• No drop counting. No mixing or shaking required
• Demonstrated efficacy and safety of ciprofloxacin and
fluocinolone acetonide2
Drop by BOOTH #218 to learn more!
IMPORTANT SAFETY INFORMATION
Contraindications
OTOVEL is contraindicated in:
• Patients with known hypersensitivity to fluocinolone acetonide or other
corticosteroids, ciprofloxacin or other quinolones, or to any other component
of OTOVEL.
• Viral infections of the external ear canal, including varicella and herpes simplex
infections and fungal otic infections.
For additional safety information, please see adjacent page for Brief Summary of
Otovel is a registered trademark of Laboratorios Salvat, Prescribing Information, and visit www.otovel.com for full Prescribing Information.
S.A. with the US Patent and Trademark Office and under
license by Arbor Pharmaceuticals, LLC.
References: 1. US Food and Drug Administration. Orange Book: approved drug products with therapeutic
© 2018 Arbor Pharmaceuticals, LLC. equivalence evaluations. https://www.accessdata.fda.gov/scripts/cder/ob/default.cfm. Accessed January 30, 2018.
All rights reserved. Printed in USA. PP-OTO-US-0255 2. Otovel [package insert]. Atlanta, GA: Arbor Pharmaceuticals, LLC.
OTOVEL® (ciprofloxacin and fluocinolone acetonide) otic solution The most common adverse reactions that occurred in 1 or more patients are as follows:
Brief Summary of Prescribing Information Table 1: Selected Adverse Reactions that Occurred in 1 or more Patients in the
OTOVEL Group
1 INDICATIONS AND USAGE
OTOVEL is indicated for the treatment of acute otitis media with tympanostomy tubes Number (%) of Patients
(AOMT) in pediatric patients (aged 6 months and older) due to Staphylococcus aureus,
Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, and OTOVEL CIPRO FLUO
Pseudomonas aeruginosa. Adverse Reactions1 N=224 N=220 N=213
2 DOSAGE AND ADMINISTRATION Otorrhea 12 (5.4%) 9 (4.1%) 12 (5.6%)
• OTOVEL is for otic use only. It is not for ophthalmic use, or for injection.
Excessive granulation tissue 3 (1.3%) 0 (0.0%) 2 (0.9%)
The recommended dosage regimen is as follows:
Ear infection 2 (0.9%) 3 (1.4%) 1 (0.5%)
• Instill the contents of one single-dose vial 0.25 mL into the affected ear canal twice
daily (approximately every 12 hours) for 7 days. Use this dosing for patients aged Ear pruritus 2 (0.9%) 1 (0.5%) 1 (0.5%)
6 months of age and older.
• Warm the solution by holding the vial in the hand for 1 to 2 minutes. This is to avoid Tympanic membrane disorder 2 (0.9%) 0 (0.0%) 0 (0.0%)
dizziness, which may result from the instillation of a cold solution into the ear canal.
Auricular swelling 1 (0.4%) 1 (0.5%) 0 (0.0%)
• The patient should lie with the affected ear upward, and then instill the medication.
Balance disorder 1 (0.4%) 0 (0.0%) 0 (0.0%)
• Pump the tragus 4 times by pushing inward to facilitate penetration of the medication
into the middle ear.
1
Selected adverse reactions that occurred in ≥ 1 patient in the OTOVEL group
• Maintain this position for 1 minute. Repeat, if necessary, for the opposite ear [see derived from all reported adverse events that could be related to the study drug or
Instructions for Use]. the drug class.
3 DOSAGE FORMS AND STRENGTHS 6.2 Postmarketing Experience
Otic Solution: Each single-dose vial of OTOVEL (ciprofloxacin 0.3 % and fluocinolone The following adverse reactions have been identified during postapproval use of
acetonide 0.025 %) delivers 0.25 mL of solution equivalent to ciprofloxacin 0.75 mg and ciprofloxacin and fluocinolone acetonide otic solution, 0.3% / 0.025% outside the US.
fluocinolone acetonide 0.0625 mg. Because these reactions are reported voluntarily from a population of uncertain size,
4 CONTRAINDICATIONS it is not always possible to reliably estimate their frequency or establish a causal
OTOVEL is contraindicated in: relationship to drug exposure.
• Patients with known hypersensitivity to fluocinolone acetonide or other • Immune system disorders: allergic reaction.
corticosteroids, ciprofloxacin or other quinolones, or to any other components • Infections and infestations: candidiasis.
of OTOVEL. • Nervous system disorders: dysgeusia, paresthesia (tingling in ears),
• Viral infections of the external ear canal, including varicella and herpes simplex dizziness, headache.
infections and fungal otic infections. • Ear and labyrinth disorders: ear discomfort, hypoacusis, tinnitus, ear congestion.
5 WARNINGS AND PRECAUTIONS • Vascular disorders: flushing.
5.1 Hypersensitivity Reactions • Skin and subcutaneous tissue disorders: skin exfoliation.
OTOVEL should be discontinued at the first appearance of a skin rash or any other • Injury, poisoning and procedural complications: device occlusion (tympanostomy
sign of hypersensitivity. Serious and occasionally fatal hypersensitivity (anaphylactic) tube obstruction).
reactions, some following the first dose, have been reported in patients receiving
systemic quinolones. Some reactions were accompanied by cardiovascular collapse, 8 USE IN SPECIFIC POPULATIONS
loss of consciousness, angioedema (including laryngeal, pharyngeal or facial edema), 8.1 Pregnancy
airway obstruction, dyspnea, urticaria and itching. Serious acute hypersensitivity Risk Summary
reactions may require immediate emergency treatment. OTOVEL is negligibly absorbed following otic administration and maternal use is
not expected to result in fetal exposure to ciprofloxacin and fluocinolone acetonide
5.2 Potential for Microbial Overgrowth with Prolonged Use [see Clinical Pharmacology (12.3)].
Prolonged use of OTOVEL may result in overgrowth of non-susceptible bacteria and
fungi. If the infection is not improved after one week of treatment, cultures should 8.2 Lactation
be obtained to guide further treatment. If such infections occur, discontinue use and Risk Summary
institute alternative therapy. OTOVEL is negligibly absorbed by the mother following otic administration and
breastfeeding is not expected to result in exposure of the infant to ciprofloxacin and
5.3 Continued or Recurrent Otorrhea fluocinolone acetonide [see Clinical Pharmacology (12.3)].
If otorrhea persists after a full course of therapy, or if two or more episodes of otorrhea
occur within 6 months, further evaluation is recommended to exclude an underlying 8.4 Pediatric Use
condition such as cholesteatoma, foreign body, or a tumor. OTOVEL has been studied in patients as young as 6 months in adequate and well-
controlled clinical trials. No major differences in safety and effectiveness have been
6 ADVERSE REACTIONS observed between adult and pediatric patients [see Indications and Usage (1) and
The following serious adverse reactions are described elsewhere in the labeling: Dosage and Administration (2)].
Hypersensitivity Reactions [see Warnings and Precautions (5.1)]
8.5 Geriatric Use
6.1 Clinical Trials Experience Clinical studies of OTOVEL did not include sufficient numbers of subjects aged 65 years
Because clinical trials are conducted under widely varying conditions, adverse reaction and over to determine whether they respond differently from younger subjects. Other
rates observed in the clinical trials of a drug cannot be directly compared to rates in the reported clinical experience has not identified differences in responses between the
clinical trials of another drug and may not reflect the rates observed in practice. elderly and younger patients.
In clinical trials, 224 patients with AOMT were treated with OTOVEL for a median 10 OVERDOSAGE
duration of 7 days. All the patients received at least one dose of OTOVEL. There were Due to the characteristics of this preparation, no toxic effects are to be expected with
220 patients who received at least one dose of ciprofloxacin (CIPRO) and 213 patients an otic overdose of OTOVEL.
received at least one dose of fluocinolone acetonide (FLUO).
OTOVEL is:
Distributed by:
Arbor Pharmaceuticals, LLC
Atlanta, GA 30328
Under license of Laboratorios SALVAT, S.A.
OTOVEL is a registered trademark of Laboratorios SALVAT, S.A.
U.S. Patent No: 8,932,610
For more detailed information, see the full prescribing information for Otovel at You are encouraged to report negative side effects of prescription drugs to the FDA.
www.otovel.com or contact Arbor Pharmaceuticals, LLC at 1-866-516-4950. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.Wednesday, April 18
ABEA LOCATION: MARYLAND B (UNLESS OTHERWISE NOTED)
WEDNESDAY, APRIL 18
7:00 am 8:29 am 9:18 am 10:42 am
ABEA Business Meeting Prevalence of Incidental Vocal Deglutition and Respiratory Motor Endplate-Expressing
Fold Pathology in Patients Patterns during Sleep in the Muscle Implants for the
7:30 am with and without Recent Aged with OSAS Treatment of Recurrent
Presidential Welcome, Endotracheal Intubation Who Kiminori Sato, MD Laryngeal Nerve Injury
Introduction of Guests and Undergo FEES Sarah Brookes, DVM
Program Cedric Thiel, BS 9:24 am
James Burns, MD Laser Soldering of a Cartilage 10:48 am
8:35 am Graft Interposed into a Tracheal Preliminary Study of a NR4A1
7:45 am Surgical and Conservative Incision in a Porcine Model Agonist, a Novel Anti-
Guest of Honor Lecture Management of Laryngeal Ari DeRowe, MD Fibrotic Agent, on Vocal Fold
Steven Zeitels, MD Contact Granuloma: A Meta- Fibroblasts
Analysis and Systematic Review 9:30 am Nao Hiwatashi, MD, PhD
Session I: Vocal Fold Shu Wei Tsai, MD Impact of Balloon Diameter on
Pathology: Diagnosis Dilation Outcomes in a Rabbit 10:52 am
8:41 am Subglottic Stenosis Model Activity of the Swallowing-
and Management Adverse Events in Recurrent Claudia Schweiger, MD, PhD Related Neurons in the Dorsal
Moderators:
Elizabeth Guardiani, MD
Respiratory Papillomatosis Medulla in Perfused Rats
Lyndsay Madden, MD Patients Treated Surgically 9:36 am Yochiro Sugiyama, MD, PhD
8:00 am with or without Adjuvant Discussion
Correlating Endoscopic Intralesional Cidofovir Dana Thompson, MD 10:58 am
Appearance of Laryngeal Rebecca Hoesli, MD Discussion
Lesions with Histopathology 9:40 am Susan Thibeault, MD
8:47 am Presidential Lecture
Mursalin Anis, MD, PhD
Discussion R Kim Davis, MD 11:10 am
8:11 am Lucian Sulica, MD Panel I: Decision Making in
Comparing Short-Term 10:00 am Surgery for Dysphagia and
Outcomes of Surgery and Session II: ABEA Coffee with Exhibitors Aspiration: Lessons Learned
Voice Therapy for Patients Horizons: Basic Maryland Foyer Moderator: Gregory Postma
Panelists:
with Vocal Fold Polyps Science of the Pediatric Peter Belafsky
Jay Agarwal, MD Aeordigestive Tract Session III: ABEA Rebecca Howell
Moderators: Horizons: Basic Michael Pitman
8:17 am David Horn, MD Science of the Adult Supported by the Voice Health Instutite
Recurrent Respiratory Jonathan Ida, MD Endowment
Aeordigestive Tract
Papillomatosis Outcomes 9:00 am
Moderators:
Following an HPV Vaccination Protective pH Neutralizing 12:00 pm
Simon Best, MD
Initiative Esophageal Irrigations as a Gregory Dion, MD ABEA Member Photograph
Yin Yiu, MD Novel Mitigation Strategy 10:30 am
for Button Battery Injury: Lubricin, A Lubricating Mucin- 12:00 pm
8:23 am A Cadaveric and Live like Glycoprotein, Detected in Adjourn/Lunch with Exhibitors
Apneic Technique in Animal Model the Lamina Propria of the True Maryland Foyer
Laryngotracheal Surgery: A Rachel Anfang, MA Vocal Fold of Humans and 6
Retrospective Review Other Mammals
Terence Zimmermann, MD 9:12 am James Kobler, PhD
Feasibility of Shotgun
Metagenomics to Assess 10:36 am
Microbial Ecology of Pediatric Laryngeal Sensory Receptor
Tracheostomy Tubes Mapping in Humans Unveils
James Wang, MD, PhD the Mechanisms of Laryngeal
Adductor Reflex Control
Catherine Sinclair, MD
www.cosm.md 9COSM 2018 PROGRAM GUIDE
Wednesday, April 18
AHNS LOCATION: (UNLESS OTHERWISE NOTED)
WEDNESDAY, APRIL 18
GENERAL SESSION/CONCURRENT 1: MARYLAND A | CONCURRENT 2: MARYLAND C
7:00 am 9:11 am CONCURRENT 1 11:13 am
The American Head and Early Results of Methylation MARYLAND A Discussion
Neck Society 2.0: Society Re- Markers with Digital Droplet
SS2: Reconstruction
Organization and Restructuring PCR for the Early Detection CONCURRENT 2
Brian Burkey, MD, Med of Head and Neck Squamous and Rehabilitation
Moderators: MARYLAND C
Ehab Hanna, MD Cell Carcinoma
Jonathan Irish, MD, MSc, FRCSC Scharukh Jalisi, MD 10:30 am
Jason Chan, MD Rahul Seth, MD Panel 2: Implementing a
Marita Teng, MD Quality Program That Actually
8:00 am 9:17 am 10:30 am Improves Quality
Welcome and Introduction of Use of Transcervical National Variations in Fibula Moderator: Christine Gourin, MD
Guest of Honor Ultrasound for Identification of Free Flaps and the Role of Panelists:
Danny Enepekides, MD, FRCS Primary Site in Patients With
D Gregory Farwell, MD
Institutional Volume in Costs Carol Lewis, MD, MPH
Jonathan Irish, MD, MSc, FRCSC
Oropharyngeal Cancer and Surgical Complication Lisa E Ishii, MD, MHS
C Burton Wood, MD Rates Charles Meltzer, MD
8:15 am Rance J Fujiwara, BS
9:23 am CONCURRENT 1
John Conley Lecture
Discussion 10:36 am MARYLAND A
Stages of Head and Neck
Cancer Over the Passage of Celecoxib Decreases 11:30 am
9:29 am Acute Postoperative Opioid Rapid Fire Session 1:
Time
Brian O’Sullivan, MD
The Learning Curve for Requirements after Head Choosing Wisely and
Introduction:
Transoral Endoscopic Thyroid and Neck Reconstruction Evidence Based
Jonathan Irish, MD, MSc, FRCSC Lobectomy with Free Tissue Transfer: A Moderators:
Christopher R Razavi, MD Matched-Cohort Study Vikas Mehta, MD
Patrick Carpenter, MD Richard Wong, MD
CONCURRENT 1
9:35 am Speakers:
MARYLAND A Jimmy Brown, MD, DDS
A Novel Flexible Robot for the 10:42 am
9:05 am Amy Hessel, MD
Treatment of Oropharyngeal Infrahyoid Flap for Reconstruc- Larry Myers, MD
Panel 1: Implications of AJCC Carcinoma in Transoral Robotic tion of Head and Neck Defects Liana Puscas, MD
Staging Changes on Clinical Surgery Marianne Nakai, MD Eugene Yu, MD
Care: The Unknown Primary Jason Chan, MD
and Oropharyngeal Cancer
10:48 am CONCURRENT 2
Moderator: William Lydiatt, MD
9:41 am Discussion
Panelists: MARYLAND C
Combining Fluorescence
Umamaheswar Duvvuri, MD, PhD
Imaging with Transoral Robotic 10:55 am
SS3: Immunotheraphy
Carole Fakhry, MD, MPH
Brian O’Sullivan, MD Surgery to improve Head and Patterns of Loss of Venous
and Adjuvant Therapies
Jose Zevallos, MD, MPH Neck Cancer Detection Moderators:
Flow in Head and Neck Ellie Maghami, MD
Larissa Sweeny, MD Microvascular Surgery with Jonathan Mark, MD
CONCURRENT 2 Double Venous Anastomoses 11:30 am
MARYLAND C 9:47 am Elliot Morse, BS
Adjuvant Radiation for
Using a Fluorescent Contrast
SS1: Technology Positive Margins in Adult H&N
Agent to Assess Surgical 11:01 am
Moderators: Sarcomas is Associated with
Sobia Khaja, MD Margins in Head and Neck Frailty as a Predictor of Improved Survival: Analysis of
Daniel Knott, MD Cancer Resections Morbidity and Mortality in the National Cancer Database
Maie St John, MD, PhD Rebecca W Gao, MS Microvascular Reconstructive Amanda J Kull, MD
9:05 am Head and Neck Patients
Computer Vision Using 9:53 am Kelly F Moyer 11:36 am
Hyperspectral Imaging & Discussion
PD-L1 May Serve as a
Machine Learning To Classify 11:07 am
Prognostic Biomarker in HPV-
Tumor, Margin, and Soft- 10:00 am Mandibular Reconstruction associated Head and Neck
Tissues of the Head and Neck Coffee with Exhibitors with the Tip of Scapula Free Cancer Patients
Shamik Mascharak, MD Maryland Foyer Flap Austin K Mattox, MD
Jeffrey Blumberg, MD
10 2018 Combined Otolaryngology Spring MeetingsAHNS CONT. LOCATION: (UNLESS OTHERWISE NOTED)
GENERAL SESSION/CONCURRENT 1: MARYLAND A | CONCURRENT 2: MARYLAND C
11:42 am CONCURRENT 1 CONCURRENT 2 3:10 pm
The Addition of Chemotherapy MARYLAND A MARYLAND C Coffee with Exhibitors
to the Adjuvant Therapy of Maryland Foyer
SS4: Thyroid SS5: Larynx/Pharynx
WEDNESDAY, APRIL 18
Late-stage Salivary Squamous
Moderators: Moderators:
Cell Carcinoma is Associated Lisa Orloff, MD Amit Agrawal, MD CONCURRENT 1
with Improved Patient Survival Nitin Pagedar, MD Susan McCammon, MD MARYLAND A
Shayan Cheraghlou, BA 2:20 pm Shawn Newlands, MD, PhD 3:40 pm
Voice Outcomes Following 2:20 pm
Panel 3: Thyroid Nodule
11:48 am Surgery for Thyroid Cancer Staging HPV-Related Best Practices and Outcome
Discussion Kevin J Kovatch, MD Oropharyngeal Cancer: Optimization
Validation of AJCC 8 in a Moderator: Michael Singer, MD
11:55 am 2:26 pm Surgical Cohort Panelists:
Adjuvant Radiation for T1- Utility of Intraoperative Frozen Mathew Geltzeiler, MD William Armstrong, MD
2N1M0 Oral Cavity Cancer Section in Large Thyroid Kevin Brumund, MD
is Associated with Improved 2:26 pm Amy Chen, MD, MPH
Nodules David Goldstein, MD, FRCSC
Survival Outcomes: Analysis Craig A Bollig, MD Towards a Tumor-specific Jacquie Jonklaas, MD, PhD, MPH
of the SEER Database De-intensification Strategy in Luc Morris, MD MSc
Hailey M Shepherd, BS 2:32 pm Oropharyngeal Squamous
Trends in Opiod Prescribing Cell Carcinomas: Using Tumor
CONCURRENT 2
12:01 pm Practices After Endocrine Immunophenotypes to Predict
MARYLAND C
Does Perioperative Surgery Patient Outcomes
Oxandrolone Improve Lauren B Moneta, MD Wesley H Stepp, PhD SS6: Survivorship
Nutritional Status in Patients Moderators:
with Cachexia Related to 2:32 pm Ehab Hanna, MD
2:38 pm
Miriam Lango, MD
Head and Neck Carcinoma? Discussion Abnormal Microvasculature Russell Smith, MD
Angela M Osmolak, MD in Laryngectomy Mucosal 3:40 pm
2:45 pm Margins Identified on Frozen
Baseline Cognition Assess-
12:07 pm
Parathyroid Hormone Level Section is Associated with
ment among Oropharyn-
Longitudinal Immune Com- Alone is Most Accurate Increased Risk of Fistula
geal Cancer Patients using
plexity Analysis Using 29- Predictor of Intravenous Marianne Abouyared, MD
PROMIS and NIH Toolbox
Biomarker Multiplex Immuno- Calcium Administration After Parul Sinha, MBBS
histochemistry in Primary and Thyroidectomy 2:38 pm
Recurrent Head and Neck Catherine Frenkel, MD Discussion 3:46 pm
Squamous Cell Carcinoma
Chronic Opioid Use in
Grace L Banik, MD 2:51 pm 2:45 pm
Patients with Oropharyngeal
A Practical Method to Predict Occult Contralateral Nodal Dis- Squamous Cell Carcinoma
12:13 pm ease in Oropharyngeal Squa-
the Severity of Hypocalcemia Treated with Radiotherapy
Discussion after Parathyroidectomy for mous Cell Carcinoma Patients Justin Dourado, MD
Primary Hyperparathyroidism Undergoing Primary TORS with
12:20 pm Changxing Liu, MD, PhD Bilateral Neck Dissection 3:52 pm
AHNS Business Meeting Caitlin McMullen, MD
Impact of Patient Symptoms
Maryland A 2:57 pm
Members Only
on Caregiver Task Burden in
2:51 pm
The Post-thyroidectomy Locally Advanced Head and
Voice: The Disconnect The Role of Intravenous Neck Cancer
12:30 pm Acetaminophen in Post-
Between Patient-perceived Emily H Castellanos, MD
Lunch with Exhibitors Voice Changes and Objective Operative Pain Control in Head
Maryland Foyer and Neck Cancer Patients
Voice Measures in the First 3:58 pm
Postoperative Year Erin J Smith, MD, MS
1:30 pm Risk of Developing New
Heidi Kletzien, MS Health Disorders Following
Keynote Lecture 2:57 pm
Head and Neck Cancer
Transforming Empathy to 3:03 pm Effect of Treatment Modality Treatment Varies Significantly
Empowerment: The 2017 Discussion on Chronic Opioid Use by Head and Neck Cancer
Invictus Games & Lessons for in Patients with T1/T2 Subsite: An Analysis of the
Growing Cancer Awareness Oropharyngeal Cancer Utah Head and Neck Cancer
and Research Craig A Bollig, MD
Survivor’s Study
Michael Burns
Marcus M Monroe, MD
Introduction by Jonathan Irish, 3:03 pm
MD, MSc, FRCSC
Discussion
www.cosm.md 11COSM 2018 PROGRAM GUIDE
Wednesday, April 18
AHNS CONT. LOCATION: (UNLESS OTHERWISE NOTED)
WEDNESDAY, APRIL 18
GENERAL SESSION/CONCURRENT 1: MARYLAND A | CONCURRENT 2: MARYLAND C
4:04 pm 4:28 pm CONCURRENT 2 CONCURRENT 2
Discussion Symptom Burden Associated MARYLAND C CHESAPEAKER C
With Late Lower Cranial 4:50 pm 6:00 pm
4:10 pm Neuropathy in Long-Term Panel 5: Sinonasal Fellowship Information Session
Racial Disparities and HPV Oropharyngeal Cancer Malignancies
Status in Oropharyngeal Survivors Moderator: 7:00 pm
Cancer Puja Aggarwal, BDS, MPH Ian Witterick, MD, MSc, FRCSC International AHNS Endocrine
Nicholas Lenze, BS Panelists: Meeting
4:34 pm Ehab Hanna, MD Maryland A
4:16 pm Discussion Michael Moore, MD
Shirley Su, MBBS
Geographic Distance to Adam Zanation, MD
Treatment Is Not Associated CONCURRENT 1
with Overall Survival MARYLAND A CONCURRENT 1
Douglas Farquhar, MD 4:50 pm
MARYLAND A
Panel 4: Best Practices and 6:00 pm
4:22 pm
Optimizing Outcomes in
Neck Disability and Health- Endocrine Section Business
Parathyroid Disease
Related Quality of Life among Meeting
Moderator: Alfred Simental, MD
Head and Neck Cancer Panelists:
Survivors Following Surgical Kenneth Burman, MD
and Non-surgical Treatment Maisie Shindo, MD
Marci L Nilsen, PhD, RN Brendan Stack, MD
David Terris, MD, FACE
AAFPRS LOCATION: MARYLAND D (UNLESS OTHERWISE NOTED)
1:00 pm 1:17 pm 1:37 pm 2:11 pm
Welcome and Introduction: Mandible Fracture Outcomes Panel Exophthalmometry in Orbital
2 Cases at a High Volume Tertiary Frontal Sinus Fractures: Shifts Reconstruction: A Pilot Study
Sydney C Butts, MD Trauma Center Toward Sinus Preservation Sarah R Akkina, MD
Travis T Tollefson, MD, MPH Tsung-yen Hsieh, MD Moderators:
Work Supported by AAFPRS Clinic Sydney C Butts, MD 2:15 pm
Investigation Research Award
Craniomaxillofacial Travis T Tollefson, MD, MPH Endoscopic Assisted
Panelists: Cranioplasty for Repair of an
Trauma – Podium 1:24 pm Oneida Arosarena, MD
Presentations Isolated Anterior Table Frontal
Analysis of Preoperative Risk Neal D Futran, MD, DMD
Moderator: Sydney C Butts, MD David Poetker, MD
Sinus Fracture: Case Report
Factors for Post-Operative and Review of Management
1:03 pm Brad Strong, MD
Complications in Facial Bradford A Woodworth, MD Options
Cost-Analysis of Orbital Floor Fracture Repair P Vairavan Manickam, MD
Implants in the Post-Traumatic Brandon Wachal, MD
Setting Craniomaxillofacial
2:19 pm
Mark M Mims, MD 1:31 pm Trauma – Show & Tell
2:10 pm
Etiology and Management
Discussion of Nasal Bone Fractures
1:10 pm Show and Tell Session
Presenting to the Emergency
Pediatric Mandible Fracture Introduction
Department of a Tertiary Care
Management at a Tertiary Moderator: Sydney C Butts, MD
Hospital
Care Center: A 7-Year
Mark A Arnold, MD
Experience of 150 Cases
Richard Kao, MD
12 2018 Combined Otolaryngology Spring MeetingsAAFPRS CONT. LOCATION: MARYLAND D (UNLESS OTHERWISE NOTED)
2:23 pm 3:23 pm Facial Reanimation – 4:52 pm
Assessment of Oral Health- Multi-Institutional Outcomes Show & Tell The Anterior Lateral Thigh
Related Quality of Life from Lateral Eyelid Coupling Moderator: Flap: Exploring the Versatility
WEDNESDAY, APRIL 18
Outcomes in Patients with for Facial Paralysis: The Travis T Tollefson, MD, MPH of a Workhorse
Mandible Fractures Using the Hybrid Tarsoconjunctival Flap 4:20 pm LCDR J Marshall Green III, DDS
GOHAI Questionnaire Raj Dedhia, MD Incongruity Between Patient
John Hamblin, MD Work Supported by AAFPRS Clinic 4:56 pm
Investigation Research Award
Self-Perception and FACE
Questionnaire: Social Func- Costal Cartilage Grafting
2:27 pm tion Scores in Facial Paralysis for Maxillary Augmentation
3:30 pm
Discussion Patients in Binder’s Syndrome-
Discussion Nasomaxillary Hypoplasia:
Jennifer R White
2:30 pm A Review of Two Cases
Membership in AAFPRS Reconstruction – 4:24 pm Mark Armeni, MD
Travis T Tollefson, MD, MPH Podium Presentations Objectively Assessing Out-
Moderator: comes of Facial Defect Recon- 5:00 pm
2:30 pm Travis T Tollefson, MD, MPH struction Using Eye-Tracking Adjourn
Coffee with Exhibitors 3:32 pm Jacob K Dey, MD
Maryland Foyer Activation of Hedgehog (Hh) 5:30 pm
Signaling Pathway Enhances 4:28 pm Essentials Course
Facial Reanimation – the Bone Regeneration The Health Utility Following Chesapeake DEF
Mediated by the Delivery of Rhinectomy, Total Nasal
Podium Presentations VEGF and BMP-6 Tethered
Introduction and Welcome/
Moderator: Reconstruction and Prosthetic Stephen Park, MD
Travis T Tollefson, MD, MPH to a Novel Polysaccharide Nasal Rehabilitation Cutaneous Lesions & Skin Flaps/
2:55 pm Scaffold in a Critical-sized Rat Olivia Quatela, BS Stephen Park, MD
Mandibular Defect Head & Neck Reconstruction/
Patient-Oriented Assessment
Matthew Q Miller, MD 4:32 pm Facial Paralysis/ Terry A Day, MD
of Online Facial Reanimation AAFPRS Bernstein Grant winner
Resources Versatility of the DAOM Flap Rhinoplasty/ Robin Lindsay, MD
Andrew H Lee, MD for Full-Thickness Upper and Facial Rejuvenation/
3:39 pm
Lower Lip Defects Edward H Farrior, MD
Functional Outcomes of
3:02 pm Taylor R Manton, MD Maxillofacial & Soft Tissue
TMJ Reconstruction with Trauma/ John Frodel, MD
Treatment Patterns and Vascularized Tissue
Outcomes in Botox Therapy 4:36 pm
Nikolaus S Hjelm, MD
for Patients with Facial Discussion
Synkinesis 3:46 pm
Justin Shinn, MD
Mohs Reconstruction Patient Reconstruction –
Show & Tell
EXHIBITOR
3:09 pm
Impact of Early Eyelid
Reported Outcome Measure
Jared Christophel, MD, MPH Moderator:
Travis T Tollefson, MD, MPH
EVENTS!
Weight Implantation on the 3:53 pm 4:40 pm
Development of Synkinesis The Grecian Urn Necklift– Checkpoint Surgical
The Pedicled Temporoparietal
and Recovery in Patients Disc“URN”ing When It’s An Alternative
Fascia Flap for Nasal Lining
With Incomplete Recovery of Indicated to Conventional
Reconstruction in Subtotal
Idiopathic Facial Palsy Ashley L Miller, MD Monitoring in Head &
Rhinectomy Defects
Keon Parsa Neck Procedures
Elizabeth A Hobbs, MD
4:44 pm Wednesday, April 18
3:16 pm 6:00 – 7:00 pm
4:00 pm Anatomic Relationship of the
The Effects of Combinatorial Nerve to the Master Muscle: A Chesapeake 4–6
Discussion
Treatments on Recovery from Cadaveric Study
Facial Nerve Injury Adrian A Ong, MD Cook Medical
4:04 pm
Morgan Sandelski, BS In-Office
Keynote
4:48 pm Sialendoscopy: Various
The Social Dimension of Facial Challenges & Keys to
Comparing Postoperative
Paralysis Success
Outcomes of Free Flap
Sofia Lyford-Pike, MD
Patients in a Specialty Thursday, April 19
Step-down Unit versus Non- 6:30 – 8:00 am
Specialty Intensive Care Unit Chesapeake 10
Shiayin F Yang, MD
www.cosm.md 13COSM 2018 PROGRAM GUIDE
Wednesday, April 18
ALA LOCATION: MARYLAND B (UNLESS OTHERWISE NOTED)
WEDNESDAY, APRIL 18
1:00 pm 1:37 pm 2:23 pm 3:39 pm
Welcome Positive Effect of Nimodipine Drug Eluting Laryngeal Expression of Trophic
Gady Har-El, MD on Vocal Fold and Facial Stents in a Mouse Model of Factors Receptors during
Motion Recovery Following Laryngeal Stenosis Reinnervation after Recurrent
President’s Address Injury - A Systematic Review Jason L Yu, MD Laryngeal Nerve Injury
From Laryngeal Oncology to and Meta-Analysis Ignacio Hernandez-Morato, PhD
Oncologic Laryngology - The R Jun Lin, MD, MSc 2:29 pm
ALA and Laryngeal Cancer Early Surgical Management of 3:45 pm
Gady Har-El, MD 1:43 pm Thermal Airway Injury: A Case Laryngeal Adductor Function
Dynamic Voice CT Scan Series Following KTP Laser Welding
Introduction of the Guest of Improves Surgical Decision Asitha Jayawardena, MD, MPH of the Recurrent Laryngeal
Honor Making for Complex Airway Nerve
Peak Woo, MD Patients Undergoing 2:35 pm Neel K Bhatt, MD
Reconstructive Voice Surgery Discussion
Mathieu Bergeron, MD, BPharm 3:51 pm
Presentation of Presidential
Citations 2:45 pm Discussion
1:49 pm Coffee with Exhibitors
Dinesh Chhetri, MD
Maxine Cunningham, MBA Prevalence and Maryland Foyer 4:00 pm
The New York Laryngological Otolaryngology Resource American Laryngological
Society Utilization for Vocal Fold Scientific Session III: Association Award
Paralysis/Paresis after Eiji Yanagisawa, MD
Injury and Healing
Recognition of the Program Esophagectomy
Moderators:
Committee Matthew G Crowson, MD Jennifer L Long, MD, PhD 4:05 pm
Dinesh Chhetri, MD Susan Thibeault, PhD, CCC-SLP Gabriel F. Tucker, MD Award
Yolanda Heman-Ackah, MD 1:55 pm 3:15 pm Noel Garabédian, MD
Natasha Mirza, MD
Voice Outcomes following Nanoparticle Delivery of
Michael Pitman, MD
Susan Thibeault, PhD Medialization Laryngoplasty RNA-Based Therapeutics 4:10 pm
VyVy N Young, MD with and without Arytenoid to Alter the Local Vocal Fold Panel Discussion
Adduction Response to Injury LEMG: What’s All the Fuss?
Terence Zimmermann, MD, MPH Ryan C Branski, PhD
Scientific Session I: Moderator: Allen Hillel, MD
Vocal Fold Paralysis 2:01 pm
Panelists:
3:21 pm Yolanda Heman-Ackah, MD
Moderators:
Randal C Paniello, MD, PhD Discussion The Ability of Conditioned Allen Hillel, MD
Sunil Verma, MD Media from Human Nasal Clark A Rosen, MD
Peak Woo, MD
1:31 pm Scientific Session II: Inferior Turbinate-derived
Resident Research Award Airway Stenosis and Mesenchymal Stem Cells to
5:00 pm
Vocal Motor Control and Injury Repair Vocal Fold Injuries
Choung-Soo Kim, MD Neurolaryngology Study
Central Auditory Impairments Moderators:
Group
in Unilateral Vocal Fold Alexander T Hillel, MD
Michael Pitman, MD 3:27 pm Spasmodic Dysphonia: Past,
Paralysis
2:11 pm Wound Healing after Transoral Present and Future
Molly Naunheim, MD
Nationwide Estimations of Angiolytic Laser Surgery for Christy Ludlow, PhD
Tracheal Stenosis Due to Early Glottic Carinoma
Tracheostomies Lauren F Tracy, MD
Romaine F Johnson, MD, MPH
3:33 pm
2:17 pm Investigation of Surgical
Healthcare Costs and Adhesives for Vocal Fold
Cost-effectiveness of Wound Closure
Laryngotracheal Stenosis Karen M Kost, MD
Linda X Yin, MD
14 2018 Combined Otolaryngology Spring MeetingsThursday, April 19
AAFPRS LOCATION: MARYLAND D (UNLESS OTHERWISE NOTED)
8:00 am Rhinoplasty – 9:29 am 10:28 am
Welcome and Introduction: Show & Tell Reconstruction of the Perception of Neck Scars After
2 Cases Moderator: Nasal Framework with an Thyroid Surgery: Is There Social
Sydney C Butts, MD Travis T Tollefson, MD, MPH Osseocartilaginous Rib Graft Value in Avoiding a Neck Scar?
Travis Tollefson, MD 9:01 am L-Strut Jason C Nellis, MD
Endoscopic Pericranial Flap Peter J Ciolek, MD
Rhinoplasty – for Nasal Septal Perforation 10:35 am
Podium Presentations Repair 9:33 am Do Trainee and Faculty
Moderator: Candace Waters, MD The Rodent Costal Cartilage Surgeons Agree About What
THURSDAY, APRIL 19
Travis T Tollefson, MD, MPH Reconstructive Model Happens in the Operating
8:05 am 9:05 am Karam W Badran, MD Room During Septoplasty
Comparison of Primary and Differences in Lateral Wall Procedures?
Secondary Anterior Septal Insufficiency Grading and 9:37 am Anand Malpani, PhD
Reconstruction: A Cohort their Correlation to Patient Rhinoplasty Publications
Study Reported Nasal Obstruction Trends: What the Literature 10:42 am
Emily Spataro, MD Measures Tells us About the Innovation in Measuring Flap Partial
Shannon Flynn Rudy Surgery and Scope of Practice Pressure of Oxygen Using
8:12 am Cameron M Heilbronn Electron Paramagnetic
Characterization of a Moldable 9:09 am Resonance Oximetry
Chondroitin Sulfate-Based Liposomal Bupivacaine 9:41 am Marc Alexander Polacco, MD
Diced Cartilage Graft for Use Does Not Increase Cost of Latinos Display Same-Race
in Rhinoplasty Rhinoplasty with Rib Cartilage Initial Gaze Preference When 10:49 am
Andrew H Lee, MD Graft Viewing Latino and Caucasian Utility of Laser Speckle
Andrew W Logeman, MD Rhinoplasty Patients Contrast Analysis in
8:19 am Michelle C Juarez, BS Measuring Tissue Perfusion in
Preoperative Expectation and 9:13 am a Rat Model
Postoperative Satisfaction Rhinoplasty Surgical Planning: 9:45 am Mofiyinfolu Sokoya, MD
in Rhinoplasty Patients: A Visualization of Nasal Cartilage Discussion
Correlation Study on MicroCT and Clinical CT 10:56 am
Cherian Kandathil, MD Protocols 9:50 am Discussion
Rajeev C Saxena, MD, MBA Membership in AAFPRS
8:25 am Sydney C Butts, MD 11:00 am
Discussion 9:17 am Keynote
The Effect of Sociodemo- 9:51 am Computer Aided Surgery in
8:30 am graphic Factors on Functional Coffee with Exhibitors Maxillofacial Reconstruction
Panel Rhinoplasty Outcomes of Na- Prince George’s Exhibit Hall A E Bradley Strong MD
A Debate: The Rhinoplasty sal Obstruction and Revision
Clinicial Practice Guidelines Surgery Emerging Technology Emerging Technology
Moderator: Brian A Nuyen, MD & Techniques – Podium & Techniques –
Travis T Tollefson, MD, MPH Presentations Show & Tell
9:21 am
Pain Management with Moderator: Sydney C Butts, MD Moderator: Sydney C Butts, MD
Discussion 10:21 am
Nonnarcotics 11:18 am
Panelist: Sydney Butts MD Mobile Applications in Facial Hair Loss Significantly
9:25 am
Plastics and Reconstructive Decreases Health Utility in
Patient Reported Outcome Short- and Long-Term Surgery Males and Females and Is
Measures Improvement in Sleep- Albert H Zhou, BS Improved Following Hair
Panelist: Sam P Most MD Disordered Breathing
Transplant Surgery
Antibiotics Outcomes after Functional
Olivia E Quatela, BS
Panelist: Lisa E Ishii, MD, MHS Septorhinoplasty
Robin Lindsay, MD
Nasal Packing and Stents
Panelist: Stephen Park, MD
www.cosm.md 15COSM 2018 PROGRAM GUIDE
Thursday, April 19
AAFPRS CONT. LOCATION: MARYLAND D (UNLESS OTHERWISE NOTED)
11:22 am 11:30 am 11:42 am 11:50 am
New Methods and Materials in Using WhatsApp to Non-invasive Video Free Flap Monitoring Using
Scaffold-Assisted Artificial Hair Complement Teaching in a Monitoring of Blood Flow Thermal Imaging
Implantation in a Rat Model Facial Reconstruction Training Validated Using Pulse Annika Meyer, MD
Roxana Moayer Module in Haiti Oximetry and the Allen Test
Work supported by previous AAFPRS Natalie Justicz, MD Annika Meyer, MD 11:54 am
Resident Research Grants
Identifying At Risk Surgical
11:34 am 11:46 am Patient Populations For
11:26 am
Discussion Post-Thyroidectomy Neck Medical Mission Trips To
THURSDAY, APRIL 19
A New Affordable Protocol for Scars Lead to Attentional Colombia
3-Dimensional Models as an 11:38 am Distraction: An Objective Collin Rozanski, BA
Aid for Orbital and Midface Measurement of Social
Readability of Online Materials
Reconstruction Attention Using Eye-Tracking 11:58 am
Related to Facial Rejuvenation
Dominick J Gadaleta, MD
Amar Gupta, MD Michelle C Juarez, BS Discussion
12:00 pm
Adjourn/ Closing Remarks/
Lunch with Exhibitors
Prince George’s Exhibit Hall A
JOIN US!
1ST COMBINED POSTER RECEPTION 2ND COMBINED POSTER RECEPTION
AAFPRS • ABEA • AHNS • ALA • ARS ANS • AOS • ASPO • TRIO
Thursday, April 19, 5:30 – 7:00 pm Friday, April 20: 5:30 – 7:00 pm
Prince George’s Exhibit Hall A Prince George’s Exhibit Hall A
16 2018 Combined Otolaryngology Spring MeetingsAHNS LOCATION: (UNLESS OTHERWISE NOTED)
CONCURRENT 1: MARYLAND A | CONCURRENT 2: MARYLAND C
6:30 am 8:07 am 11:00 am 1:31 pm
AHNS Networking Breakfast Infratemporal Fossa Jatin Shah Symposium: Delays During Treatment for
Sponsored by the Women in AHNS Resections in Patients with Personalized Medicine – Laryngeal Squamous Cell
Committee, Diversity Task Force and
Young AHNS Members Task Force
Advanced Cutaneous Non- Can We Afford It? Carcinoma: An Analysis of the
Chesapeake 7–9 melanoma Malignancies Moderator: David Eisele, MD National Cancer Database
of the Head and Neck: A Speakers: Elliot Morse, BS
Retrospective Analysis of John de Almeida, MD, MSc
CONCURRENT 1 Robert Ferris, MD, PhD
Surgical Cases at a Single, 1:37 pm
MARYLAND A James Rocco, MD, PhD
Tertiary Referral Center Ashok Shaha, MD The Role of TRAF3/CYLD
SS7: Skin Cancer Patrick F Morgan, MD Mutations in the Etiology of
Moderators: Human Papillomavirus-driven
12:00 pm
Babak Givi, MD 8:13 am Cancers of the Head and Neck
Kevin McLoughlin Higgins, MD, Lunch with Exhibitors
FRCSC
Discussion Prince George’s Exhibit Hall A Tejas S Sathe
Aru Panwar, MD
7:30 am CONCURRENT 2 1:43 pm
THURSDAY, APRIL 19
CONCURRENT 1
The Impact of Immunosup- MARYLAND C Discussion
MARYLAND A
pression on Head & Neck 7:30 am
Cutaneous Squamous Cell
SS8: Best Papers of CONCURRENT 2
Panel 6: Reconstruction -
Carcinoma Prognosis: A Cutting Guides vs. Cutting AHNS 2018 MARYLAND C
Systematic Review of the Moderators:
Costs: The Value of 3D 1:00 pm
Peter Dziegielewski, MD, FRCSC
Literature with Meta-Analysis Modelling and Virtual Surgical Tanya Fancy, MD Panel 7: Focus on Function –
Alhasan N Elghouche, MD, MS Planning Benjamin Judson, MD Maximizing Survivorship and
Moderator: 1:00 pm Quality of Life After Treatment
7:36 am Danny Enepekides, MD, FRCS Moderator:
The Impact of the Affordable
Outcomes of Biopsy Panelists: Rosemary Martino, MSc, PhD
Trinitia Cannon, MD
Care Act on Insurance
Techniques Prior to Sentinel Coverage for Head and Neck Panelists:
Douglas Chepeha, MD Liza Blumenfeld, MA, CCC-SLP,
Lymph Node Biopsy for Brett Miles, MD Cancer: A Population-Based
Primary Cutaneous Melanoma BCS-S
Urjeet Patel, MD Analysis Timothy McCulloch, MD
of the Head and Neck Matthew Spector, MD Richard B Cannon, MD Barbara Messing, MA, CCC-SLP
Matthew May, MD Bevan Yueh, MD
CONCURRENT 1 1:06 pm
7:42 am
MARYLAND A Occult Nodal Disease and CONCURRENT 1
Oncologic Outcomes Following 8:30 am Occult Extranodal Extension MARYLAND A
Primary Surgical Therapy in Oropharyngeal Squamous
Hayes Martin Lecture 2:00 pm
for Advanced Basal Cell Cell Carcinoma Patients
Carcinoma of the Head and Connecting Health Systems Rapid Fire Session 2:
Research and Health System Undergoing Primary TORS Choosing Wisely and
Neck with Neck Dissection
Amarbir S Gill, MD Improvement. The Role of Evidence Based
Caitlin McMullen, MD
Governance and Policy Moderators:
Adalsteinn Brown, AB, DPhil Vikas Mehta, MD
7:48 am 1:12 pm Richard Wong, MD
Introduction by Jonathan Irish,
Discussion MD, MSc, FRCSC Perioperative Gabapentin Panelists:
use Among Head and Neck Antoine Eskander, MD, ScM,
7:55 am FRCSC
9:15 am Surgical Patients
Becky Massey, MD
Auriculotemporal Nerve AHNS Research Awards Melanie E Townsend, MD Cherie-Ann Nathan, MD
Involvement in Parotid Bed Cecelia Schmalbach, MD, MS
Malignancy 9:30 am 1:18 pm Catherine Sinclair, MD, FRACS
James D Thompson, MD Discussion
Coffee with Exhibitors
Prince George’s Exhibit Hall A
8:01 am 1:25 pm
Patient-specific Three- 10:00 am Differences in Opioid Utilization
dimensional Printed Tissue- Presidential Address after Major Head and Neck
equivalent Bolus for Radio- Procedures: A Comparison of
Reflections
therapy of Head and Neck Institutions in Hong Kong and
Jonathan Irish, MD, MSc, FRCSC
Malignancies Involving Skin Introduction by Ehab Hanna, MD the United States
Brandon A Dyer, MD Ryan J Li, MD
www.cosm.md 17COSM 2018 PROGRAM GUIDE
Thursday, April 19
AHNS CONT. LOCATION: (UNLESS OTHERWISE NOTED)
CONCURRENT 1: MARYLAND A | CONCURRENT 2: MARYLAND C
CONCURRENT 2 2:42 pm 3:36 pm 4:18 pm
MARYLAND C Depth of Invasion as a Utility of the LACE index Impact of Facility Head and
Predictor of Nodal Disease in Predicting 30-day Neck Cancer Resection
SS9: Oral Cavity
and Survival in Patients with Readmission Rate in Volume On Positive Margin
Moderators:
Caitlin McMullen, MD, BS Oral Tongue Squamous Cell Head and Neck Free Flap Rate
Jeremy Richmon, MD Carcinoma Microvascular Reconstruction Cheryl C Nocon, MD
John Yoo, MD, FRCSC Samantha Tam, MD Patients
2:00 pm Ashley M Bauer, MD 4:24 pm
Prognostic Performance of 2:48 pm Discussion
THURSDAY, APRIL 19
the AJCC 8th Edition Staging Discussion 3:42 pm
System in Patients with Early Value of Intensive Care CONCURRENT 1
Oral Tongue Cancer 3:00 pm Unit–Based Management MARYLAND A
Moran Amit, MD Coffee with Exhibitors for Microvascular Free Flap 4:30 pm
Prince George’s Exhibit Hall A Reconstruction in Head and
Panel 9: The Importance of
2:06 pm Neck Surgery
Gender Equality in Lifting All
Is Oral Cavity Cancer in Young CONCURRENT 1 Pratyusha Yalamanchi
Boats
Non-smokers Biologically MARYLAND A Moderator:
Distinct? 3:48 pm
3:30 pm Catherine Sinclair, MD, FRACS
Kathryn M Vorwald, DDS, MD
Panel 8: Advances in Skin An Analysis of Processes Panelists:
Cancer Management of Care Measures Related Marion Couch, MD, PhD
2:12 pm
Moderator: Kevin Emerick, MD
to Delayed Postoperative Eben Rosenthal, MD
Comprehensive Analysis Radiation Therapy in Patients Ozlem Tulunay, MD
Panelists:
of Minor Salivary Gland Peter Ahn with Surgically-Treated Head
Malignancies of the Head and Arnaud Bewley, MD and Neck Cancer CONCURRENT 2
Neck Geoffrey Gibney Tyler A Janz, BS MARYLAND C
Jamie Oliver Samir Khariwala, MD 4:30 pm
Kelly Malloy, MD 3:54 pm Panel 10: Head and Neck
2:18 pm Discussion Cancer Cooperative Group
Discussion CONCURRENT 2 Clinical Trials: Updates and
MARYLAND C 4:00 pm New Trial Concepts
2:30 pm SS10: Quality Identifying Predictors of Moderator: Steve Chang, MD
Analysis of Risk Factors Engineering and Depression Development Panelists:
Associated with Unplanned Pathways in Head and Neck Cancer Steve Chang, MD
Patients Robert Ferris, MD, PhD
Reoperation Following Major Moderators: Katherine Hutcheson, MD
Cancer Operations of the Marc Cohen, MD, MPH Aru Panwar, MD
Rosemary Martino, MSc, PhD
Head and Neck Vasu Divi, MD John Ridge, MD, PhD
Neel R Sangal, BA Kristen Pytynia, MD, MPH 4:06 pm
3:30 pm Treatment Delays in Primarily- 5:30 pm
2:36 pm Effectiveness of Non-opioid/ Resected Oropharyngeal AHNS Poster Tours
Transcriptomic Profile of Non-narcotic Postoperative Squamous Cell Carcinoma: Prince George’s Exhibit Hall A
Squamous Cell Carcinoma of Pain Management Regimen An Analysis of the National
the Tonsil is Unique Compared for Patients Undergoing Cancer Database 7:30 pm
to other Head and Neck Thyroidectomy and/or Elliot Morse
AHNS President’s Reception
Neoplasms Parathyroidectomy National Harbor 11
Shijun Sung, PhD James R Biery, PAC 4:12 pm
Development of Multimodal
Analgesia Pathway in
Outpatient Thyroid Surgery
is Associated with Dramatic
Reduction in Opioid Use
Aru Panwar, MD
18 2018 Combined Otolaryngology Spring MeetingsALA LOCATION: MARYLAND B (UNLESS OTHERWISE NOTED)
Scientific Session IV: Scientific Session 9:45 am 10:43 am
Cancer and Dysphagia V: Hyerfunction and Coffee with Exhibitors Premeability and Weibel-
Prince George’s Exhibit Hall A Palade Bodies of the Blood
Moderators: Presbylarynx
Peter Belafsky, MD, PhD Vessels in the Human Vocal
Moderators:
Joel Blumin, MD Michael M Johns III, MD Scientific Session VI: Fold Mucosa
8:00 am VyVy N Young, MD Physiology Kiminori Sato, MD, PhD
Molecular and Immunologic 8:40 am Moderators:
Analysis of Tumors from Auditory-Perceptual and Dinesh Chhetri, MD 10:50 am
Non-smokers with Laryngeal Acoustic Evaluation of Sid Khosla, MD Discussion
Squamous Cell Carcinoma the Effects of Deep Brain 10:15 am
Ian-James Malm, MD Stimulation on Voice in High-Resolution in Vivo 11:00 am
Dystonia Patients Coronal Cross-Sectional Panel Discussion
8:06 am Lyndsay L Madden, DO Imaging of the Vocal Fold Innovation in Laryngology:
Outcomes of during Phonation Using Long- Update, Challenges, and
Tracheoesophageal Puncture 8:46 am Range Optical Coherence Future Directions
THURSDAY, APRIL 19
in Twice-Radiated Patients Laryngeal Botulinum Toxin Tomography: First Report Moderator: Mark S Courey
Kate Clancy, MD Injection for Vocal Tremor: of a Novel Diagnostic Tool Panelists:
The Utility of Concurrent Strap to Evaluate Vocal Fold Martin Burchell, MD
8:12 am Muscle Injection Morphometry and Kinematics Alexander Gelbard, MD
Giriraj K Sharma, MD, MS Timothy McCullough, MD
Trans-Oral Tubed Rebecca C Nelson, MD
Zhaoyan Zhang, PhD
Supraglottoplasty:
A New Approach to 8:52 am 10:22 am
11:50 am
Intracatable Aspiration Casselberry Award Young Faculty/
Yue Ma, MD Practitioner Award ALA Research Grant Award
Rejuvenation of Aged Larynx
with Alginate/Hyaluronic Acid Unearthing a Consistent
11:53 am
8:18 am
Hydrogel Which Release Basic Bilateral R1 Component of
Airway Closure Delay: The the Laryngeal Adductor Reflex ALA Poster Presentation Awards
Fibroblast Growth Factor
Predominant Pathophysiology (bFGF) Slowly in Awake Humans: A Stride
11:55 am
in Reflux-Associated Dysphagia Seong Keun Kwon, MD, PhD Forward in Our Understanding
Katherine A Kendall, MD of Laryngeal Pathophysiology Introduction of the ALA 2019
Catherine F Sinclair, MD President
8:58 am
8:24 am
Geriatric Dysphonia: Different 12:00 pm
Does Dysphagia Improve 10:29 am
Diagnoses in Different Cohorts
Following Laryngeal Chemical Receptors of the Ajourn / Lunch with Exhibitors
of Older Adults in a Specialty
Larynx: A Comparison of Prince George’s Exhibit Hall A
Reinnervation for Treatment Voice Clinic
of Hoarseness in Vocal Fold Lee Akst, MD Human and Mouse
Paralysis? Marie Jette, PhD 12:05 pm
Simon Brisebois, MD, MSc Group Photo (Members Only)
9:04 am
10:36 am Maryland Ballroom FOyer
Discussion
8:30 am A Novel Means of Evaulating
Discussion 9:13 am Laryngeal Myoelectric Activity
Introduction of State of the Art Through High Density Surface
Lecturer Electromyography: An Intuitive
Gady Har-El, MD
Visualization Method of
Laryngeal Muscle Activity
9:17 am David Bracken, MD
State of the Art Lecture
The State of the Art in
Managing Conflicts and
Disruptive Behavior in Surgery
Melina Kibbe, MD
www.cosm.md 19You can also read
